New Enterprise Associates 16, L.P. 13D and 13G filings for Genocea Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-05-27 4:34 pm Sale |
2022-05-25 | 13D | Genocea Biosciences, Inc. GNCA |
New Enterprise Associates 16, L.P. | 0 0.000% |
-15,414,495 (Position Closed) |
Filing |
| 2021-04-13 7:08 pm Sale |
2020-07-24 | 13D | Genocea Biosciences, Inc. GNCA |
New Enterprise Associates 16, L.P. | 15,414,495 26.300% |
-1,558,333 (-9.18%) |
Filing |
| 2020-08-03 2:22 pm Purchase |
2020-07-24 | 13D | Genocea Biosciences, Inc. GNCA |
New Enterprise Associates 16, L.P. | 16,972,828 48.700% |
8,004,211 (+89.25%) |
Filing |